feed,title,long_url,short_url
MedRxiv,"Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial",https://medrxiv.org/cgi/content/short/2024.02.23.24302586v1?rss=1,https://da.gd/2Q31V
MedRxiv,Global patterns of rebound to normal RSV dynamics following COVID-19 suppression,https://medrxiv.org/cgi/content/short/2024.02.23.24303265v1?rss=1,https://da.gd/QRFF
